Wanguang J. Zhang
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Progress in local therapy for gastrointestinal peritoneal metastatic tumors
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: April 27, 2026
The circadian architecture of tumor immunity: mechanistic insights and treatment strategies.
Journal: Biomarker research
Published: April 04, 2026
Utility of the Iwate Difficulty Scoring System for the Stratification of Laparoscopic Right Hepatectomies: An International Multicenter Study.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: January 18, 2026
Molecular epidemiological characteristics of human coronavirus NL63 in Shanghai City from 2019 to 2024
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: December 22, 2025
ASO Author Reflections: Who Benefits From Adjuvant PD-1 Inhibition? Navigating Time-Dependent Efficacy in Resected HCC.
Journal: Annals of surgical oncology
Published: October 09, 2025
Liver resection versus transarterial chemoembolization plus PD-1 inhibitors and lenvatinib for hepatocellular carcinoma with portal vein tumour thrombus.
Journal: BJS open
Published: September 22, 2025
Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: the initial results of a randomized controlled clinical trial (STELLAR II)
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: September 18, 2025
LIPUS as a potential strategy for anti-inflammation and repair: A review of the mechanisms.
Journal: International journal of medical sciences
Published: September 10, 2025
Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma.
Journal: Annals of surgical oncology
Published: August 26, 2025
The liver-bone axis: an emerging player in disease pathogenesis and therapeutic intervention.
Journal: Science China. Life sciences
Published: August 24, 2025
Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: July 16, 2025
Deuterium modification of tyrosine kinase inhibitors contributes to reversing ferroptosis resistance through upregulation of aldehyde oxidase 1 in hepatocellular carcinoma.
Journal: Acta pharmaceutica Sinica. B
Published: July 07, 2025
Last Updated: 09/26/2026